Letter to the Editor
Initial experience with aflibercept in the management of patients with wet age-related macular degeneration refractory to ranibizumab and/or bevacizumab
Experiencia inicial con aflibercept intravítreo en la degeneración macular asociada a la edad exudativa refractaria al tratamiento con ranibizumab o bevacizumab
R.E. Cervera
, V. Castro, J. Montero, C. Torralba, A. Gracia
Corresponding author
Servicio de Oftalmología, Hospital General Universitario, Valencia, Spain
Read
967
Timeswas read the article
231
Total PDF
736
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2018 February | 5 | 2 | 7 |
| 2018 January | 1 | 1 | 2 |
| 2017 December | 1 | 0 | 1 |
| 2017 November | 8 | 0 | 8 |
| 2017 October | 7 | 1 | 8 |
| 2017 September | 2 | 2 | 4 |
| 2017 August | 7 | 5 | 12 |
| 2017 July | 9 | 2 | 11 |
| 2017 June | 14 | 6 | 20 |
| 2017 May | 16 | 6 | 22 |
| 2017 April | 17 | 28 | 45 |
| 2017 March | 25 | 12 | 37 |
| 2017 February | 25 | 0 | 25 |
| 2017 January | 10 | 0 | 10 |
| 2016 December | 28 | 5 | 33 |
| 2016 November | 14 | 6 | 20 |
| 2016 October | 24 | 16 | 40 |
| 2016 September | 17 | 2 | 19 |
| 2016 August | 17 | 4 | 21 |
| 2016 July | 14 | 2 | 16 |
| 2016 June | 15 | 3 | 18 |
| 2016 May | 13 | 3 | 16 |
| 2016 April | 10 | 2 | 12 |
| 2016 March | 22 | 1 | 23 |
| 2016 February | 15 | 8 | 23 |
| 2016 January | 17 | 5 | 22 |
| 2015 December | 15 | 9 | 24 |
| 2015 November | 12 | 4 | 16 |
| 2015 October | 16 | 5 | 21 |
| 2015 September | 12 | 4 | 16 |
| 2015 August | 7 | 3 | 10 |
| 2015 July | 11 | 6 | 17 |
| 2015 June | 9 | 1 | 10 |
| 2015 May | 14 | 6 | 20 |
| 2015 April | 18 | 12 | 30 |
| 2015 March | 21 | 4 | 25 |
| 2015 February | 10 | 3 | 13 |
| 2015 January | 26 | 3 | 29 |
| 2014 December | 24 | 7 | 31 |
| 2014 November | 21 | 3 | 24 |
| 2014 October | 30 | 8 | 38 |
| 2014 September | 46 | 6 | 52 |
| 2014 August | 46 | 12 | 58 |
| 2014 July | 45 | 13 | 58 |
Show all
